Redeye: ADDvise - Solid Organic and Inorganic Momentum

2023-02-24 07:18:00

Redeye raises its Base Case and forecasts for ADDvise following a strong Q4 and the recent letters of intent to acquire. Organic and acquired EBITDA growth was solid, and the order intake suggests continued momentum. The company is still trading at a substantial discount to its larger peers.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.